443 related articles for article (PubMed ID: 31872264)
1. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
[TBL] [Abstract][Full Text] [Related]
3. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis.
Smedema JP; van Geuns RJ; Ector J; Heidbuchel H; Ainslie G; Crijns HJGM
ESC Heart Fail; 2018 Feb; 5(1):157-171. PubMed ID: 28967698
[TBL] [Abstract][Full Text] [Related]
4. Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis.
Velangi PS; Chen KA; Kazmirczak F; Okasha O; von Wald L; Roukoz H; Farzaneh-Far A; Markowitz J; Nijjar PS; Bhargava M; Perlman D; Akçakaya M; Shenoy C
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1395-1405. PubMed ID: 31954639
[TBL] [Abstract][Full Text] [Related]
5. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
[TBL] [Abstract][Full Text] [Related]
6. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Right Ventricular Function in Patients With Suspected Myocarditis Undergoing Cardiac Magnetic Resonance.
Bernhard B; Schnyder A; Garachemani D; Fischer K; Tanner G; Safarkhanlo Y; Stark AW; Schütze J; Pavlicek-Bahlo M; Greulich S; Johner C; Wahl A; Benz DC; Kwong RY; Gräni C
JACC Cardiovasc Imaging; 2023 Jan; 16(1):28-41. PubMed ID: 36599567
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of RV Abnormalities on CMR in Patients With Known or Suspected Cardiac Sarcoidosis.
Wang J; Zhang J; Hosadurg N; Iwanaga Y; Chen Y; Liu W; Wan K; Patel AR; Wicks EC; Gkoutos GV; Han Y; Chen Y
JACC Cardiovasc Imaging; 2023 Mar; 16(3):361-372. PubMed ID: 36752447
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction.
Pi SH; Kim SM; Choi JO; Kim EK; Chang SA; Choe YH; Lee SC; Jeon ES
J Cardiovasc Magn Reson; 2018 Jun; 20(1):36. PubMed ID: 29898740
[TBL] [Abstract][Full Text] [Related]
11. High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis.
Agoston-Coldea L; Kouaho S; Sacre K; Dossier A; Escoubet B; Chillon S; Laissy JP; Rouzet F; Kutty S; Extramiana F; Leenhardt A; Borie R; Crestani B; Ou P
Int J Cardiol; 2016 Nov; 222():950-956. PubMed ID: 27526366
[TBL] [Abstract][Full Text] [Related]
12. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
Pöyhönen P; Kivistö S; Holmström M; Hänninen H
BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
[TBL] [Abstract][Full Text] [Related]
13. Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis.
Wan K; Sun J; Han Y; Luo Y; Liu H; Yang D; Cheng W; Zhang Q; Zeng Z; Chen Y
Heart Vessels; 2018 Feb; 33(2):170-179. PubMed ID: 28840397
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.
Murtagh G; Laffin LJ; Beshai JF; Maffessanti F; Bonham CA; Patel AV; Yu Z; Addetia K; Mor-Avi V; Moss JD; Hogarth DK; Sweiss NJ; Lang RM; Patel AR
Circ Cardiovasc Imaging; 2016 Jan; 9(1):e003738. PubMed ID: 26763280
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.
Zipse MM; Tzou WS; Schuller JL; Aleong RG; Varosy PD; Tompkins C; Borne RT; Tumolo AZ; Sandhu A; Kim D; Freeman AM; Weinberger HD; Maier LA; Sung RK; Nguyen DT; Sauer WH
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1939-1948. PubMed ID: 31257683
[TBL] [Abstract][Full Text] [Related]
17. Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance.
Smedema JP; van Geuns RJ; Ainslie G; Ector J; Heidbuchel H; Crijns HJGM
ESC Heart Fail; 2017 Nov; 4(4):535-544. PubMed ID: 29154434
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular entropy is a novel predictor of major adverse cardiac events (MACE) in patients with coronary atherosclerosis: a multi-center study.
Wang WX; Gao Y; Wang J; Liu MX; Gu H; Yuan XS; Wang XM
Eur Radiol; 2024 May; 34(5):3411-3421. PubMed ID: 37889269
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.
Houard L; Amzulescu MS; Colin G; Langet H; Militaru S; Rousseau MF; Ahn SA; Vanoverschelde JJ; Pouleur AC; Gerber BL
Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011680. PubMed ID: 33438438
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and Prognostic Value of Cardiac Magnetic Resonance Strain in Suspected Myocarditis With Preserved LV-EF: A Comparison Between Patients With Negative and Positive Late Gadolinium Enhancement Findings.
Chen Y; Sun Z; Xu L; Liu J; Li Y; Zhang N; Liu D; Wen Z
J Magn Reson Imaging; 2022 Apr; 55(4):1109-1119. PubMed ID: 34369030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]